$26.00
2.04% yesterday
Nasdaq, Sep 27, 10:02 pm CET
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

XOMA Corporation Stock price

$26.00
-3.47 11.77% 1M
+2.66 11.40% 6M
+7.50 40.54% YTD
+11.54 79.81% 1Y
+0.65 2.56% 3Y
+7.24 38.59% 5Y
-59.40 69.56% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.52 2.04%
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

Key metrics

Market capitalization $298.23m
Enterprise Value $275.60m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 18.08
P/S ratio (TTM) P/S ratio 19.57
P/B ratio (TTM) P/B ratio 2.97
Revenue growth (TTM) Revenue growth 277.95%
Revenue (TTM) Revenue $15.24m
EBIT (operating result TTM) EBIT $-19.55m
Free Cash Flow (TTM) Free Cash Flow $-8.94m
Cash position $144.60m
EPS (TTM) EPS $-2.49
P/E forward negative
P/S forward 11.49
EV/Sales forward 10.61
Short interest 3.05%
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a XOMA Corporation forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a XOMA Corporation forecast:

Buy
67%
Hold
33%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
15 15
278% 278%
100%
- Direct Costs 0.45 0.45
39% 39%
3%
15 15
348% 348%
97%
- Selling and Administrative Expenses 33 33
39% 39%
214%
- Research and Development Expense 1.24 1.24
727% 727%
8%
-19 -19
6% 6%
-125%
- Depreciation and Amortization 0.45 0.45
39% 39%
3%
EBIT (Operating Income) EBIT -20 -20
7% 7%
-128%
Net Profit -18 -18
28% 28%
-120%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
5 days ago
EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA's Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to...
Neutral
GlobeNewsWire
24 days ago
EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following September 2024 investor conferences:
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website www.xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today